ERS Licenses its CRISPR-Cas9 Patent Portfolio to Otsuka
shot by IP News Shots / 8:00 pm on 04 March, 2021
ERS Genomics has announced that it has granted a license to its CRISPR-Cas9 patent portfolio to Otsuka Pharmaceutical Co., Ltd. Otsuka plans to use the portfolio for its internal R&D programs for addressing areas of unmet medical need. The financial and other terms of the agreement have not been disclosed.
Read more at: https://www.genomeweb.com/business-news/ers-genomics-licenses-crispr-patents-otsuka-pharmaceutical
Industry: Biotechnology
Vivlion Signs a Deal with the Broad Institute for CRISPR/Cas9 Patent Portfolio
shot by IP News Shots / 9:10 pm on 02 March, 2021
Vivlion GmbH has announced that it has signed a non-exclusive license deal with the Broad Institute of MIT and Harvard. The deal gives Vivlion access to CRISPR/Cas9 intellectual property, i.e., patent portfolio from the Broad Institute as well as its partners.
Read more at: https://www.einnews.com/pr_news/536112160/vivlion-licenses-crispr-cas9-patent-portfolio-from-broad-institute
Industry: Biotechnology
WiLAN and Subsidiary Polaris Enter into a License Deal, Settle Litigation with LG Electronics
shot by IP News Shots / 9:06 pm on 02 March, 2021
WiLAN Inc. and its subsidiary Polaris Innovations Ltd. have entered into a licensing deal and have also settled litigation related to TV as well as display technologies with LG Electronics Inc. Notably, the licensed patents relate to digital display, TV technologies, and memory interface technologies. The terms and conditions of the deal have not been divulged.
Read more at: https://www.prnewswire.com/news-releases/wilan-and-subsidiary-sign-license-with-lg-301236839.html
Industry: Hardware & Equipment
ERS Genomics Enters into a Licensing Agreement with G+FLAS
shot by IP News Shots / 6:57 pm on 24 February, 2021
ERS Genomics Limited has announced the signing of a non-exclusive licensing agreement with G+FLAS Life Sciences for the former’s CRISPR-Cas9 patent portfolio. The financial terms of the agreement have not been divulged.
Industry: Biotechnology
Hasler Licenses Purdue University’s REE Separation and Purification Tech to Medallion
shot by IP News Shots / 7:03 pm on 19 February, 2021
Medallion Resources Limited has entered into a licensing agreement for exclusive rights to the rare earth element separation and purification technology from Hasler Ventures LLC. The license for this technology developed by Purdue University provides Medallion with complete rights to its patents and know-how.
Read More at: https://www.streetinsider.com/dr/news.php?id=17993811&gfv=1
Industry: Metal & Mining
TiVo Licenses Patents to Sharp in Expanded Multi-year Agreement
shot by IP News Shots / 8:18 pm on 17 February, 2021
TiVo, a subsidiary of Xperi Holding Corporation, has extended a multi-year contract with Sharp Corporation. As per the terms of the contract, the extension will also include an expanded a multi-year license for the patent portfolios owned by TiVo.
Industry: Entertainment